Rzeszotarski W J, Gibson R E, Simms D A, Jagoda E M, Vaughan J N, Eckelman W C
J Med Chem. 1983 May;26(5):644-8. doi: 10.1021/jm00359a005.
A series of 1-(aralkylamino)-3-(aryloxy)propan-2-ols were synthesized, and their apparent dissociation constants (Kapp) were determined by using rat ventricular muscle (RVM) and rat lung membrane (RLM) preparations. Analysis of the binding studies suggests the existence of different modes of binding dependent on the presence or absence of the 4-substituent in the aryloxy ring and the nature of that ring. Without 4-substitution only one compound (4), bearing the 2-(2-methoxyphenoxy)ethyl substituent on the amino group, shows high cardioselectivity. Introduction of the 4-acylamido substituent into the phenoxy ring renders all compounds cardioselective. The cardioselective influence of 4-substitution is diminished or eliminated when the phenoxy ring is replaced by naphth-1-yloxy.
合成了一系列1-(芳烷基氨基)-3-(芳氧基)丙-2-醇,并使用大鼠心室肌(RVM)和大鼠肺膜(RLM)制剂测定了它们的表观解离常数(Kapp)。结合研究分析表明,根据芳氧基环中4-取代基的存在与否以及该环的性质,存在不同的结合模式。在没有4-取代的情况下,只有一种化合物(4),其氨基上带有2-(2-甲氧基苯氧基)乙基取代基,表现出高心脏选择性。将4-酰氨基取代基引入苯氧基环使所有化合物具有心脏选择性。当苯氧基环被萘-1-基氧基取代时,4-取代的心脏选择性影响减弱或消除。